NAFLD Study Group symposium: NAFLD and the diabetologist
Thursday, 19 September 2019, 12:00 - 14:00, Hall 4.2
Chairs: H. Yki-Järvinen, FI, J. Jones, PT
Introduction to the EASD-NAFLD study group
R. Taylor, UK: NAFLD in the pathogenesis of type 2 diabetes
C. Byrne, UK: Management of diabetes in patients with cirrhosis: which treatments, which targets?
Kenneth Cusi, US: Pioglitazone in the treatment of NAFLD and fibrosis